IRIS
BERNASCONI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.226
AS - Asia 5.870
EU - Europa 4.966
SA - Sud America 665
AF - Africa 62
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.095
CN - Cina 3.608
SG - Singapore 1.221
UA - Ucraina 1.015
IE - Irlanda 977
DE - Germania 627
HK - Hong Kong 624
FI - Finlandia 599
BR - Brasile 559
SE - Svezia 437
IT - Italia 434
RU - Federazione Russa 432
GB - Regno Unito 217
VN - Vietnam 177
FR - Francia 95
CA - Canada 78
AR - Argentina 46
JP - Giappone 44
IN - India 38
MX - Messico 37
BD - Bangladesh 34
NL - Olanda 31
IQ - Iraq 23
PL - Polonia 21
ZA - Sudafrica 21
BE - Belgio 17
ID - Indonesia 17
TR - Turchia 16
EC - Ecuador 15
AT - Austria 14
ES - Italia 14
PY - Paraguay 13
VE - Venezuela 13
MA - Marocco 10
AU - Australia 9
PK - Pakistan 9
UZ - Uzbekistan 9
IR - Iran 8
KE - Kenya 7
RO - Romania 7
AZ - Azerbaigian 6
LT - Lituania 6
SA - Arabia Saudita 6
UY - Uruguay 6
EU - Europa 5
PE - Perù 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
HN - Honduras 4
IL - Israele 4
MU - Mauritius 4
CO - Colombia 3
GR - Grecia 3
JO - Giordania 3
KR - Corea 3
PA - Panama 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
LK - Sri Lanka 1
MW - Malawi 1
MY - Malesia 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UG - Uganda 1
Totale 18.805
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.241
Chandler 1.073
Dublin 977
Nanjing 951
Hong Kong 623
Ashburn 538
Dallas 502
Singapore 455
Boardman 435
Nanchang 413
Beijing 345
Shenyang 270
Princeton 261
Lawrence 260
Changsha 255
Hebei 254
Wilmington 228
Jiaxing 206
Medford 179
New York 159
Los Angeles 154
Tianjin 153
Hangzhou 142
Ann Arbor 109
Buffalo 103
Milan 95
Redondo Beach 94
Helsinki 77
Moscow 75
Ho Chi Minh City 60
Shanghai 55
Woodbridge 51
Norwalk 48
São Paulo 47
Munich 45
Tokyo 42
Toronto 41
Verona 39
Hanoi 37
Seattle 32
Turku 29
Jinan 28
Zhengzhou 27
Des Moines 24
Fairfield 23
Kunming 21
Pavia 21
Guangzhou 20
Brooklyn 19
London 19
Rome 19
Montreal 18
Ningbo 18
Warsaw 18
Brussels 17
Houston 17
Rio de Janeiro 17
Santa Clara 17
Belo Horizonte 15
Chicago 15
The Dalles 15
Orem 13
San Francisco 13
Atlanta 12
Denver 12
Falkenstein 12
Falls Church 12
Johannesburg 12
Lanzhou 12
Taizhou 12
Washington 12
Da Nang 11
Mexico City 11
Nuremberg 11
Curitiba 10
Fuzhou 10
Auburn Hills 9
Baghdad 9
Columbus 9
Frankfurt am Main 9
Phoenix 9
Tashkent 9
Vienna 9
Qingdao 8
Stockholm 8
Juiz de Fora 7
Manchester 7
Novokuznetsk 7
Orange 7
Porto Alegre 7
Pune 7
Querétaro 7
Secaucus 7
Ankara 6
Baku 6
Bologna 6
Changchun 6
Dalian 6
Goiânia 6
Guayaquil 6
Totale 11.893
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 162
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome. 147
FISH vantaggi e svantaggi 140
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma 134
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. 131
Alcaloidi della vinca e dell'epipodofillotossina 124
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 121
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) 120
Blast phase of essential thrombocythemia: A single center study. 119
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 119
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma 119
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 117
[Multiple myeloma localized in the superior maxillary. Description of an uncommon case]. 115
Alterazioni del cariotipo nelle sindromi mielodisplastiche: significato patologico e clinico 115
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? 113
Acute myeloid leukemia and diabetes insipidus: results in five patients 113
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 112
Acute nonlymphocytic leukemia : evidence of clonogenic cells in perypheral blood early in complete remission 109
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 107
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 105
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 103
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 102
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 101
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 100
La citogenetica e la biologia molecolare nella valutazione del chimerismo e della malattia minima residua 99
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 97
Alterazioni citogenetiche nelle leucemie linfatiche croniche 97
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 97
ABL1 amplification in T-cell acute lymphoblastic leukemia. 96
Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution. 95
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 95
Central nervous system relapse in acute promyelocytic leucemia 93
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 92
Iperplasia gengivale da Ciclosporina-A nel paziente emopatico: considerazioni cliniche 91
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 91
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 90
A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia. 90
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 90
Impiego della citosina a basse dosi: risultati global 89
Valutazione prognostica dele sindromi mielodisplastiche 89
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma 89
Analisi citogenetica e molecolare in onco-ematologia: rilevanza per diagnosi, prognosi e scelte terapeutiche 89
Alternative Splicing of hTERT: a further Mechanism for the Control of Active hTERT in Acute Myeloid Leukaemia 89
Treatment of relapsed and refractory acute myloid leukemia in adults 87
Additional chromosomal abnormalities in Ph positive clone: adverse prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML analysis. 87
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 87
Il controllo odontostomatologico nel paziente affetto da emopatia maligna: studio preliminare 86
Alterazioni citogenetiche nelle leucemie acute 85
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 85
Growth factors in the therapy of myelodisplasia: biological aspects. 84
Molecularly targeted therapy in acute myeloid leukemia. 83
Importanza clinica della malattia minima residua nel post-trapianto” Progetto “Progressi in Biologia e Medicina 83
Etoposide : il citostatico della linea monocitica 83
Exercise intolerance at high altitude (5050 m): critical power and W'. 83
Controllo delle infezioni nelle leucemie acute 83
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 83
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 83
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 82
Autoimmunita’ nella malattia da trapianto contro l’ospite 82
Leucemia mielomonocitica cronica 82
Significance of MLC for BMT with serological HLA-identical related and unrelated donors 82
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 82
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 81
Selezione delle cellule CD 34 positive. 81
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 80
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 80
Storia naturale e trasformazione istologico/clinica dei linfomi a bassa malignita’. 80
Localizzazione di mieloma multiplo al mascellare superiore 80
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 79
Fattori di crescita emopoietici (G-CSF e GM-CSF) nel trapianto di midollo osseo allogenico 79
Rischio infettivologico in pazienti affetti da leucemia acuta e sottoposti a trapianto di midollo osseo autologo. Studio di 14 casi 79
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 78
Role of the molecular staging and response in the management of follicular lymphoma patients 77
Telomero e telomerasi:biologia e osservazioni preliminari nelle neoplasie ematologiche 76
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 76
Evolving approaches with alpha interferon in chronic myelogenous leukemia 76
Interessamento del cromosoma 3 nelle mielodisplasie (MDS) 76
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 76
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation. 76
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis 76
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? 75
L’ibridazione in situ per documentare il chimerismo e l’origine della recidiva nel trapianto allogenico di midollo osseo 75
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 74
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. 74
Hematopoietic growth factors in bone marrow transplantation 73
Prompt response to high-dose intravenous immunoglobulins given as first-line therapy in post-transplant thrombocytopenic purpura 73
Burkitt’s lymphoma/leukemia : a clinico-pathologic study on 24 adult patients. 73
Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset 72
Nephrotic sindrome after allogeneic hemopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 72
IL SISTEMA TELOMERO/TELOMERASI: UN NUOVO BERSAGLIO IN EMATOLOGIA/ONCOLOGIA 72
Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. 72
Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study 72
Il trapianto di midollo osseo allogenico nel trattamento della leucemia acuta 72
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 72
Complicanze emorragiche e trombotiche nel paziente chirurgico 72
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia—analysis of 848 patients 72
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 72
Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report 72
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci. 71
Bone Marrow transplantation from unrelated donors in myelodysplastic syndromes 71
Totale 9.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.167 0 0 0 0 0 243 6 264 63 270 265 56
2021/20221.015 14 7 37 15 26 64 19 82 61 23 156 511
2022/20233.159 362 203 7 259 394 367 0 219 1.188 25 83 52
2023/20241.126 102 213 30 108 112 396 8 65 11 33 13 35
2024/20252.895 47 322 76 98 81 59 159 252 629 74 230 868
2025/20263.377 446 504 807 811 697 112 0 0 0 0 0 0
Totale 18.933